Paclitaxel plus high-dose cyclosphosphamide with G-CSF support in patients with relapsed and refractory aggressive non-Hodgkin's lymphoma-Reference-Cited by-同舟云学术

Paclitaxel plus high-dose cyclosphosphamide with G-CSF support in patients with relapsed and refractory aggressive non-Hodgkin's lymphoma

Published:1998-12 Issue:3 Volume:103 Page:678-683
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:British Journal of Haematology

Author:

Younes Anas,Romaguera Jorge,Mesina Ofelia,Hagemeister Frederick,Sarris Andreas H.,Rodriguez Maria A.,Mclaughlin Peter,Preti Hector A.,Bachier Carlos,Cabanillas Fernando

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.1998.01048.x/fullpdf

Reference17 articles.

1. Chemotherapy for non-Hodgkin's lymphoma;Armitage;Current Opinion in Oncology,1992

2. Treatment of non-Hodgkin's lymphoma;Armitage;New England Journal of Medicine,1993

3. Peripheral-blood stem-cell collections after paclitaxel, cyclophosphamide, and recombinant human granulocyte colony-stimulating factor in patients with breast and ovarian cancer;Demirer;Journal of Clinical Oncology,1995

4. Dose escalation of paclitaxel with high-dose cyclophosphamide, with analysis of progenitor-cell mobilization and hematologic support of advanced ovarian cancer patients receiving rapidly sequenced high-dose carboplatin/cyclophosphamide courses;Fennelly;Journal of Clinical Oncology,1995

5. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma;Fisher;New England Journal of Medicine,1993

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An overview on anti-tubulin agents for the treatment of lymphoma patients;Pharmacology & Therapeutics;2020-07

2. Successful alemtuzumab retreatment in progressive B-cell chronic lymphocytic leukemia: a multicenter survey in 30 patients;Annals of Hematology;2011-02-25

3. Perspectives on cancer therapy-induced mucosal injury;Cancer;2004

4. Rituximab-Mediated Sensitization of B-Non-Hodgkin's Lymphoma (NHL) to Cytotoxicity Induced by Paclitaxel, Gemcitabine, and Vinorelbine;Cancer Biotherapy and Radiopharmaceuticals;2002-12

5. Diffuse Large B-cell Lymphoma with Infiltration-Associated Peripheral Neuropathy and Paraneoplastic Myopathy with a Prolonged Course Over Seven Years;Leukemia & Lymphoma;2002-01